piperazine has been researched along with ciprofloxacin in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Foroumadi, A; Kiani, Z; Mansouri, S; Rahmani, A | 1 |
| Azéma, J; Dewelle, J; Guidetti, B; Kiss, R; Korolyov, A; Le Calve, B; Malet-Martino, M; Martino, R; Mijatovic, T; Vaysse, J | 1 |
| Izard, D; Mullié, C; Sonnet, P | 1 |
| Jiang, W; Korshin, GV; Liu, C; Nanaboina, V | 1 |
| Cao, TY; Duan, NN; Hou, LL; Hu, GQ; Huang, WL; Wang, GQ; Wang, W; Wen, XY; Xie, SQ; Yin, J | 1 |
| Abdel-Aziz, AA; Al-Suwaidan, IA; Alanazi, AM; Asiri, YA; Ayyad, RR; El-Azab, AS; Maarouf, AR; Shawer, TZ | 1 |
| Cochrane, WG; Fitzgerald, PR; Paegel, BM | 1 |
| Abbasi, MA; Ali Shah, SA; Irshad, M; Rehman, A; Shahid, M; Siddiqui, SZ | 1 |
9 other study(ies) available for piperazine and ciprofloxacin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Synthesis and in vitro antibacterial evaluation of N-[5-(5-nitro-2-thienyl)-1,3,4-thiadiazole-2-yl] piperazinyl quinolones.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Enoxacin; Microbial Sensitivity Tests; Norfloxacin; Piperazine; Piperazines; Quinolones | 2003 |
7-((4-Substituted)piperazin-1-yl) derivatives of ciprofloxacin: synthesis and in vitro biological evaluation as potential antitumor agents.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Ciprofloxacin; Humans; Maximum Tolerated Dose; Mice; Neoplasms; Piperazine; Piperazines | 2009 |
Prevalence of efflux-mediated ciprofloxacin and levofloxacin resistance in recent clinical isolates of Pseudomonas aeruginosa and its reversal by the efflux pump inhibitors 1-(1-naphthylmethyl)-piperazine and phenylalanine-arginine-β-naphthylamide.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dipeptides; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Membrane Transport Proteins; Microbial Sensitivity Tests; Ofloxacin; Piperazine; Piperazines; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections | 2012 |
Spectroscopic study of degradation products of ciprofloxacin, norfloxacin and lomefloxacin formed in ozonated wastewater.
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Fluoroquinolones; Mass Spectrometry; Norfloxacin; Oxidation-Reduction; Ozone; Piperazine; Piperazines; Quinolones; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical | 2012 |
Part IV: Design, synthesis and antitumor activity of fluoroquinolone C-3 heterocycles: bis-oxadiazole methylsulfide derivatives derived from ciprofloxacin.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; CHO Cells; Ciprofloxacin; Cricetinae; Cricetulus; Drug Design; HL-60 Cells; Humans; Inhibitory Concentration 50; Leukemia L1210; Molecular Structure; Oxadiazoles; Piperazine; Piperazines | 2012 |
Synthesis and potential antitumor activity of 7-(4-substituted piperazin-1-yl)-4-oxoquinolines based on ciprofloxacin and norfloxacin scaffolds: in silico studies.
Topics: 4-Quinolones; Antineoplastic Agents; Cell Line; Cell Proliferation; Ciprofloxacin; Computer Simulation; Humans; Molecular Structure; Norfloxacin; Piperazine; Piperazines; Structure-Activity Relationship | 2016 |
Antibacterial Discovery via Phenotypic DNA-Encoded Library Screening.
Topics: Anti-Bacterial Agents; Apoptosis; Bacillus subtilis; Ciprofloxacin; DNA; Drug Discovery; Escherichia coli; Gene Library; High-Throughput Screening Assays; Molecular Structure; Piperazine; Structure-Activity Relationship | 2021 |
N-Sulfonated derivatives of (2-furoyl)piperazine: Promising antibacterial agents with mild cytotoxicity.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Microbial Sensitivity Tests; Piperazine | 2022 |